AFT Pharmaceuticals (AFT Pharmaceuticals) EV-to-FCF : 0.00 (As of Jun. 23, 2024)

AFT Pharmaceuticals EV-to-FCF Chart

AFT Pharmaceuticals Annual Data
	Trend	Mar16	Mar17	Mar18	Mar19	Mar20	Mar21	Mar22	Mar23	Mar24
EV-to-FCF		Get a 7-Day Free Trial				47.07	-101.57	47.92	161.56	18.02

AFT Pharmaceuticals Quarterly Data
	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24
EV-to-FCF	Get a 7-Day Free Trial												47.92	-	161.56	-	18.02

Competitive Comparison of AFT Pharmaceuticals's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, AFT Pharmaceuticals's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

AFT Pharmaceuticals's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, AFT Pharmaceuticals's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where AFT Pharmaceuticals's EV-to-FCF falls into.

AFT Pharmaceuticals EV-to-FCF Calculation

AFT Pharmaceuticals's EV-to-FCF for today is calculated as:

AFT Pharmaceuticals's current Enterprise Value is $0.00 Mil.
AFT Pharmaceuticals's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $11.72 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AFT Pharmaceuticals  (OTCPK:AFTPF) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

AFT Pharmaceuticals's PE Ratio for today is calculated as:

AFT Pharmaceuticals's share price for today is $0.00.
AFT Pharmaceuticals's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.000.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.

AFT Pharmaceuticals EV-to-FCF Related Terms

Thank you for viewing the detailed overview of AFT Pharmaceuticals's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.

AFT Pharmaceuticals (AFT Pharmaceuticals) Business Description